Japan approved an updated Moderna COVID-19 vaccine targeting variant JN.1 for the 2024/2025 immunization program.
Japan has approved an updated COVID-19 vaccine from Moderna targeting the SARS-CoV-2 variant JN.1, following a recommendation from a Japanese health ministry panel in May to update vaccines for the 2024/2025 national immunization program. The updated vaccine aims to better protect against circulating strains and could be administered alongside seasonal flu vaccines in the future. The approval supports Japan's National Immunization Program, which offers vaccinations to individuals aged 65 and older, as well as qualifying individuals aged 60 to 64.
August 22, 2024
20 Articles